Gastrointestinal stromal tumors: a spectrum of disease

Cord Sturgeon1, Gregorio Chejfec, N Joseph Espat

  • 1Department of Surgery, University of Illinois at Chicago, M/C 958, 840 S. Wood Street, Room 435E CSB, Chicago, IL 60612, USA.

Surgical Oncology
|April 12, 2003
PubMed

Insights

Gastrointestinal stromal tumors (GIST) often have c-kit mutations, driving cancer growth. Tyrosine kinase inhibitors are key treatments, alongside surgery, for advanced GIST.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the GI tract.
  • Most GISTs express the c-kit receptor tyrosine kinase, a key factor in tumor development.

Observation:

  • Mutations in the c-kit proto-oncogene can lead to uncontrolled activation of the receptor.
  • This constitutive activation drives neoplastic transformation and tumor growth.

Findings:

  • Selective tyrosine kinase inhibitors (TKIs) effectively target the activated c-kit in GIST.
  • TKIs are now standard chemotherapy for metastatic or unresectable GIST.
  • Complete surgical resection remains the primary treatment modality for GIST.

Implications:

  • TKIs show promise as adjuvant therapy for GIST, with ongoing clinical trials.
  • Accurate diagnosis of GIST is crucial to differentiate from other mesenchymal tumors due to distinct prognoses and treatment responses.
  • Targeting GIST tyrosine kinase offers a specific therapeutic strategy for this malignancy.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...